Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-265-2 | CAS number: 93783-70-1
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation assay (Ames) is in progress and expected to be negative.
Mammalian cell gene mutation test (HPRT method): negative
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
An AMES test on the target substance is in progress.
The results of the available HPRT assay performed according to OECD guideline 476 on the target substances were also reported.
Chinese hamster V79 cells were treated with test substance dissolved in DMEM. Three cytoxicity experiments were run to assess the optimal dose range; tested concentrations ranged for 0.0005 to 2 mg/ml. Based on cytotoxicity results, concentrations for main test with and without metabolic activation (S9-mix) were chosen. In particular:
- 0.01, 0.015, 0.02 (discarded as redundant), 0.025, 0.03 and 0.04 mg per ml without S9 -mix
- 0.02, 0.05, 0.075, 0.1 nad 0.2 (discarded as completely toxic) mg per ml with S9 -mix.
Positive and negative controls were valid.
Under test conditions, test substance resulted as non mutagenic in this assay.
Justification for classification or non-classification
Based on currently available data, i.e. expected negative Ames assay, negative HPRT assay target substance is considered as not mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
